About Contact Us Careers

Congenital Anomalies Treatment Market Trends

Request Free Sample Copy

Report ID: 2702
Published Date: Sep 03, 2024
Report Format: PDF, PPT

Buy Now

Congenital Anomalies Treatment Market Trends

Growth Drivers

Increasing Prevalence of Congenital Anomalies
Growing Health Awareness amongst Individuals

Challenges

High Cost of Defect Screening
High Treatment Cost and Unfavorable Healthcare Policies

Congenital Anomalies Treatment Market: Key Insights

Base Year	2023
Forecast Year	2024–2036
CAGR	4.6%
Base Year Market Size (2023)	USD 158.5 million
Forecast Year Market Size (2036)	USD 284.41 million
Regional Scope	North America (U.S., and Canada) Latin America (Mexico, Argentina, Rest of Latin America) Asia-Pacific (Japan, China, India, Indonesia, Malaysia, Australia, Rest of Asia-Pacific) Europe (U.K., Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe) Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)

Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:

Congenital Anomalies Treatment Market Size & Share, Forecast Report 2036

Author Credits: Radhika Pawar

Report ID: 2702
Published Date: Sep 03, 2024
Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2024, the industry size of congenital anomalies treatment is estimated at USD 164.33 million.

Congenital Anomalies Treatment Market size was valued at USD 158.5 million in 2023 and is likely to reach USD 284.41 million by 2036, registering around 4.6% CAGR during the forecast period i.e., between 2024-2036. Increasing prevalence of congenital anomalies will boost the market growth.

Asia Pacific is poised to dominate majority revenue share by 2036, on the back of advancements in the healthcare sector, and rising healthcare expenditure across the region.

The major players in the market are GlaxoSmithKline plc, Regeneron Pharmaceuticals, Inc., BioMarin Pharmaceutical Inc., Amgen Inc., Alexion Pharmaceuticals, Inc., Merck KGaA, Novartis International AG, Ipsen Pharma, Fresenius Kabi USA, and others.

Inquiry Before Buying Request Free Sample